Balance Sheet
Cash Flow Statement
AmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Change in Inventory (2017 - 2020)

Historic Change in Inventory for Dr Reddys Laboratories (RDY) over the last 17 years, with Q3 2025 value amounting to $869.1 million.

  • Dr Reddys Laboratories' Change in Inventory rose 155345.24% to $869.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $869.1 million, marking a year-over-year increase of 78192.48%. This contributed to the annual value of -$149.0 million for FY2025, which is 3257.92% up from last year.
  • As of Q3 2025, Dr Reddys Laboratories' Change in Inventory stood at $869.1 million, which was up 155345.24% from -$71.9 million recorded in Q2 2025.
  • In the past 5 years, Dr Reddys Laboratories' Change in Inventory registered a high of $869.1 million during Q3 2025, and its lowest value of -$75.8 million during Q2 2024.
  • Over the past 5 years, Dr Reddys Laboratories' median Change in Inventory value was $619.0 million (recorded in 2021), while the average stood at $492.9 million.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Change in Inventory tumbled by 11367.82% in 2024, and later soared by 155345.24% in 2025.
  • Dr Reddys Laboratories' Change in Inventory (Quarter) stood at $670.8 million in 2021, then dropped by 8.29% to $615.1 million in 2022, then decreased by 28.93% to $437.1 million in 2023, then tumbled by 113.68% to -$59.8 million in 2024, then surged by 1553.45% to $869.1 million in 2025.
  • Its Change in Inventory stands at $869.1 million for Q3 2025, versus -$71.9 million for Q2 2025 and $820.9 million for Q1 2025.